Heroin Dependence: all 88 studies
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use DisorderTerminatedNCT04495673Not applicableResults posted
- Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent IndividualsTerminatedNCT03711318Phase 3Results posted
- Change the Cycle: An RCT to Prevent Injection InitiationCompletedNCT02774954Not applicableResults posted
- Extended-Release Naltrexone Opioid Treatment at Jail Re-EntryCompletedNCT01999946Phase 4Results posted
- Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/NaloxoneCompletedNCT01760473Phase 3Results posted
- Pioglitazone for Heroin and for Nicotine DependenceTerminatedNCT01395797Phase 1/2Results posted
- Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical TrialCompletedNCT00684554Phase 2/3Results posted
- Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot NaltrexoneCompletedNCT00577408Phase 3Results posted
- Buprenorphine for PrisonersCompletedNCT00574067Phase 3Results posted
- Memantine as a Supplement to Naltrexone in Treating Heroin DependenceCompletedNCT00476242Phase 2/3Results posted
- Methadone Maintenance for PrisonersCompletedNCT00378079Phase 3Results posted
- The Therapeutic Workplace Initiation StudyCompletedNCT00249470Not applicableResults posted
- Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1CompletedNCT00218634Not applicableResults posted
- Addiction Treatment in Russia: Oral vs. Naltrexone ImplantCompletedNCT00218426Phase 2/3Results posted
- Employment-based Reinforcement of Naltrexone Ingestion and AbstinenceCompletedNCT00149669Not applicableResults posted
- Repetitive Transcranial Magnetic Stimulation to Reduce Heroin CravingsCompletedNCT05074524Not applicable
- Neuroimaging and CBD for Opioid Use DisorderCompletedNCT04567784Phase 2
- Methadone Induced Memory Retrieval-extinction Procedure in Heroin AddictsCompletedNCT04133974Not applicable
- PET/MRI Study on the Neurological Mechanism of rTMS Treatment for Heroin AddictionStatus unknownNCT04086459Not applicable
- Laser Meridian Massage in Heroin AddictsStatus unknownNCT04003077Not applicable
- The Effect of Self-Forgiveness on Self-Stigma in Addiction.CompletedNCT03971097Not applicable
- Efficacy of Repetitive Transcranial Magnetic Stimulation and Cognitive Behavioral Therapy on Heroin DependenceStatus unknownNCT03922659Not applicable
- University of Houston Drug Abuse Research Development Program IIStatus unknownNCT03557632Not applicable
- Repetitive Transcranial Magnetic Stimulation in Patients With Opioid Use DisordersStatus unknownNCT03229642Not applicable
- Economic Evaluation Comparing CCT With MMT in Hai Phong City, VietnamCompletedNCT03071315
- Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid AbstinenceCompletedNCT03015246Phase 1/2
- Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in MalaysiaStatus unknownNCT02541526Phase 3
- An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS DependenceStatus unknownNCT02541513Phase 3
- An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS DependenceStatus unknownNCT02541500Phase 3
- Methadone Maintenance Outcome Study in Taiwan: 5-year Follow-upStatus unknownNCT02524912
- Biomarkers of Injectable Extended Release Naltrexone TreatmentCompletedNCT02324725Phase 4
- Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT.CompletedNCT02062736
- Observational Study to Assess the Efficacy and Tolerability of Eptadone®, in Heroin Addicted Patients in a MMTCompletedNCT02062723
- Diversion to Treatment for Injection Drug Users Arrested for Possession of HeroinCompletedNCT01723527Phase 1
- Decision Making Deficit and DNA Methylation in Opioid Receptor Genes Among Community Heroin AddictsStatus unknownNCT01668732
- Pharmacogenomics Study of Sleep Disturbance and Neurocognitive Impairments in the Opioid AddictsCompletedNCT01668706
- Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After DetoxificationCompletedNCT01580163Not applicable
- Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone EffectsCompletedNCT01536925
- Aprepitant Effects in Intravenous Heroin DependenceCompletedNCT01527994Phase 1
- Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECTCompletedNCT01471145Phase 4
- Malmö Treatment Referral and Intervention StudyCompletedNCT01457872Not applicable
- Study to Assess Longer-term Opioid Medication Effectiveness (SALOME)CompletedNCT01447212Phase 3
- Study of Computer-Based Treatment for Drug DependenceCompletedNCT01315184Phase 2
- Effect Study of Optimized Intervention to Heroin AddictsStatus unknownNCT01144390Not applicable
- Methadone Maintenance Treatment Outcome Study in TaiwanStatus unknownNCT01093248
- Variance of Oral Methadone Dosage: Description of Implicated FactorsCompletedNCT00894452
- Effect of Stress on Heroin-Related Memory RetrievalCompletedNCT00759005Not applicable
- Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine PatchesStatus unknownNCT00750217Phase 4
- Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate AbusersStatus unknownNCT00726960Phase 1
- Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, IndiaWithdrawnNCT00709007Phase 2/3
- Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)CompletedNCT00698737
- Effects of Stress and Other Factors on Opiate Drug Choice.CompletedNCT00684840
- Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk ReductionStatus unknownNCT00609089Phase 1/2
- Effects of Environmental Factors on Opiate Drug Choice in Opioid Dependent Individuals.CompletedNCT00608504
- Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary CareCompletedNCT00471042
- Sustained Release d-Amphetamine & Buprenorphine on Drug Seeking Behavior in Opioid & Cocaine Dependent IndividualsCompletedNCT00429767
- Behavioral Naltrexone Therapy: A Novel Treatment for Heroin DependenceCompletedNCT00332228Phase 2
- Effects of Buspirone in Opiate WithdrawalCompletedNCT00326235Phase 4
- Effect of Clonidine on Responses to Imagery ScriptsCompletedNCT00318760Phase 1
- A Stepwise Strategy Utilizing Buprenorphine and MethadoneCompletedNCT00310934Phase 4
- Directly Administered HIV Therapy in Methadone ClinicsCompletedNCT00279110Phase 2/3
- Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1CompletedNCT00249574Not applicable
- Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2CompletedNCT00249457Not applicable
- Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1CompletedNCT00238914Phase 2
- Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1CompletedNCT00218530Phase 1
- Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent IndividualsCompletedNCT00218361
- Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent IndividualsCompletedNCT00218309
- Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing RegimensCompletedNCT00218127Phase 2
- The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1CompletedNCT00158288Phase 2
- Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin AddictsCompletedNCT00142948Phase 2
- Addition of Naltrexone to Methadone TaperCompletedNCT00135759Phase 2
- Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1CompletedNCT00032968Phase 3
- Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1CompletedNCT00032955Phase 3
- Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1CompletedNCT00023283Phase 2
- Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14CompletedNCT00015340Phase 4
- Buprenorphine and Naloxone Combination Study - 10CompletedNCT00015288Phase 1
- Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1CompletedNCT00015171Phase 3
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6WithdrawnNCT00000331Phase 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5WithdrawnNCT00000330Phase 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4WithdrawnNCT00000329Phase 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3WithdrawnNCT00000328Phase 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2WithdrawnNCT00000327Phase 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1WithdrawnNCT00000326Phase 2
- Study Comparing Liquid and Tablet Buprenorphine Formulations - 5CompletedNCT00000302Phase 3
- A Laboratory Model for Heroin Abuse Medications - 8CompletedNCT00000273Phase 2
- Effects of Dynorphin 1-13 on Heroin Addiction - 1CompletedNCT00000244Phase 2
- Treatment Efficacy for Drug Abuse and AIDS Prevention - 2CompletedNCT00000211Phase 2
- Treatment Efficacy for Drug Abuse and AIDS Prevention - 1CompletedNCT00000210Phase 2